New diagnostic methods to monitor blood disorders enabled by bio-rad's droplet digital PCR technology showcased at 2019 Ash Annual Meeting

(CG Life) Scientists will present over 40 abstracts highlighting research driven in part by Droplet Digital PCR (ddPCR) technology at ASH. The research presented will illustrate the sensitivity, precision, and speed of Bio-Rad's ddPCR, which enables researchers and clinicians to monitor biomarkers of malignant and nonmalignant blood disorders cost-effectively and at scale.